Company / AR per Share
ResMed AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$6.40
FY2025
5-year range
$3.95 / $6.40
FY2021-FY2025
Trend
+12.3%
vs FY2024
Sector context
#36 of 141
Health Care
What the data says
At $6.40, ResMed's ar per share ranks #36 of 141 in the Health Care sector. AR per Share has increased for 3 consecutive years, from $3.95 in FY2022 to $6.40 in FY2025.
Based on SEC 10-K filings.
6.40 in FY2025 with a 5-year CAGR of +14.1%. Top quartile in the Health Care sector.
Improved from $4.81 to $6.40 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- +14.1%
- 10-Year CAGR
- -
Sector benchmark
#36 of 141 in Health CareTop 26% of 141This company $6.40 Sector average $11.78
▼
-45.7% below sector average
Key checks
Key Insights
- ResMed's ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 12.3% year-over-year.
- Ranks #36 out of 141 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.40 | +12.3% |
| FY2024 | $5.69 | +18.2% |
| FY2023 | $4.81 | +21.8% |
| FY2022 | $3.95 | -6.7% |
| FY2021 | $4.24 | +28.3% |
| FY2020 | $3.30 | -10.8% |
| FY2019 | $3.70 | +8.9% |
| FY2018 | $3.40 | +6.2% |
| FY2017 | $3.20 | +17.8% |
| FY2016 | $2.72 | +5.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026